Cited by 123Retinal Diseases and TreatmentsRetinal Development and DisordersRetinal Imaging and Analysis

Drusen in patient-derived hiPSC-RPE models of macular dystrophies

Open access
Galloway, Chad A., Dalvi, Sonal, Hung, Sandy S. C., MacDonald, Leslie A., Latchney, Lisa R., Wong, Raymond C. B., Guymer, Robyn H., Mackey, David A. +6 more·2017·Proceedings of the National Academy of Sciences

Abstract

Age-related macular degeneration (AMD) and related macular dystrophies (MDs) are a major cause of vision loss. However, the mechanisms underlying their progression remain ill-defined. This is partly due to the lack of disease models recapitulating the human pathology. Furthermore, in vivo studies have yielded limited understanding of the role of specific cell types in the eye vs. systemic influences (e.g., serum) on the disease pathology. Here, we use human induced pluripotent stem cell-retinal pigment epithelium (hiPSC-RPE) derived from patients with three dominant MDs, Sorsby's fundus dystrophy (SFD), Doyne honeycomb retinal dystrophy/malattia Leventinese (DHRD), and autosomal dominant radial drusen (ADRD), and demonstrate that dysfunction of RPE cells alone is sufficient for the initiation of sub-RPE lipoproteinaceous deposit (drusen) formation and extracellular matrix (ECM) alteration in these diseases. Consistent with clinical studies, sub-RPE basal deposits were present beneath both control (unaffected) and patient hiPSC-RPE cells. Importantly basal deposits in patient hiPSC-RPE cultures were more abundant and displayed a lipid- and protein-rich "drusen-like" composition. Furthermore, increased accumulation of COL4 was observed in ECM isolated from control vs. patient hiPSC-RPE cultures. Interestingly, RPE-specific up-regulation in the expression of several complement genes was also seen in patient hiPSC-RPE cultures of all three MDs (SFD, DHRD, and ADRD). Finally, although serum exposure was not necessary for drusen formation, COL4 accumulation in ECM, and complement pathway gene alteration, it impacted the composition of drusen-like deposits in patient hiPSC-RPE cultures. Together, the drusen model(s) of MDs described here provide fundamental insights into the unique biology of maculopathies affecting the RPE-ECM interface.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1710430114

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • iPS-RPE from patients with different monogenic forms of macular degeneration accumulate drusen deposits after 90 days of culture.

    “and iPS-RPE from patients with different monogenic forms of macular degeneration were observed to accumulate drusen deposits after 90 days of culture (Galloway et al., 2017).”

    From The cell biology of the retinal pigment epithelium (2020) · cites this paper as Galloway et al., 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [44]Sitterley G. Laminin. BioFiles. 2008;3:11. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=BioFiles&title=Laminin&author=G%20Sitterley&volume=3&publication_year=2008&pages=11&)]

Cited by

Sorted by citations

Authors
Galloway, C. A., Dalvi, S., Hung, S. S. C., MacDonald, L. A., Latchney, L. R., Wong, R. C. B., Guymer, R. H., Mackey, D. A., Williams, D. S., Chung, M. M., Gamm, D. M., Pébay, A., Hewitt, A. W., & Singh, R.
Affiliations
  • University of Rochester Medicine (US)
  • The University of Melbourne (AU)
  • Lions Eye Institute (AU)
  • University of California, Los Angeles (US)
  • University of Wisconsin–Madison (US)
  • University of Tasmania (AU)
Venue
Proceedings of the National Academy of Sciences
Published
2017-09-06
Volume
114
Issue
39
Pages
E8214-E8223
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2750719761
Cited by
123
References
65
Citations by year
2026: 11 · 2025: 8 · 2024: 18 · 2023: 11 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 14 · 2018: 10
FWCI
9.87
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • UTAS Research Repository (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
  • Figshare (submittedVersion, cc-by)
Funders
  • BrightFocus Foundation (M2015267)
  • Foundation Fighting Blindness (TA-RM-0616-0702-UR)
  • Research to Prevent Blindness (RPB-Singh, RPB-Feldon)
  • Knights Templar Eye Foundation (KTEF-Singh)
  • Retina Research Foundation (RRF-Singh)
  • Australian Research Council (ARC-Pebay)
  • The Ophthalmic Research Institute of Australia (ORIA-Hewitt)
  • David Bryant Trust (DBT-Singh)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
drusen, macular dystrophy, age-related macular degeneration, retinal pigment epithelium, Sorsby's fundus dystrophy, Malattia Leventinese, extracellular matrix, type IV collagen, complement pathway, serum exposure, disease modeling
MeSH terms
Blindness, Cells, Cultured, Humans, Macular Degeneration, Retinal Drusen, Optic Disk Drusen, Eye Diseases, Hereditary, Extracellular Matrix Proteins, Bruch Membrane, Tissue Inhibitor of Metalloproteinase-3, Collagen Type IV, Retinal Pigment Epithelium, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review